Annual report pursuant to Section 13 and 15(d)

Stock Options (Details Textual)

v2.4.0.8
Stock Options (Details Textual) (USD $)
12 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Sep. 30, 2011
Maximum [Member]
Sep. 30, 2011
Minimum [Member]
Sep. 27, 2011
Directors [Member]
Sep. 27, 2011
Employees [Member]
Sep. 30, 2011
AxoGen Plan [Member]
Dec. 31, 2012
AxoGen Plan [Member]
Dec. 31, 2011
AxoGen Plan [Member]
Sep. 27, 2011
AxoGen Plan [Member]
Dec. 31, 2012
AxoGen Plan [Member]
Maximum [Member]
Dec. 31, 2012
AxoGen Plan [Member]
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Issuance of shares 18,144,658                   2,750,000    
Merger options to purchase shares were available for issuance 1,799,991 1,945,688 447,659                    
Issuance of shares under AxoGen Plan               2,300,000          
Shares vested percentage           25.00% 12.50%            
Vested period, Description               every six months over a four-year period          
Options issued to consultants vest over the service period       10 years 3 years                
Options term range                       P10Y P7Y
Weighted average period 3 years 15 days               0 years        
Average fair value of options granted                 $ 2.99 $ 0.42      
Intrinsic value of options exercised                 $ 173,000 $ 190,000      
Intrinsic value of options outstanding   1,126,000             288,000        
Intrinsic value of options exercisable   391,000             0        
Common stock ratio 0.03727336               0.03727336        
Incremental cost                 19,769 38,521      
Total future stock compensation expense related to nonvested awards 1,405,000               1,405,150        
Stock Options (Textual) [Abstract]                          
Vesting Period 1 year                        
Stock-based compensation expense $ 495,077 $ 250,044                      
Stock options granted 267,576 1,141,952